Analogous to the 2022 European Thyroid Association Guideline for the management of paediatric Graves’ disease (2), Dr Karlsson suggests considering total thyroidectomy followed by levothyroxine supplementation in patients with MCT8 deficiency. The gene discussed is SLC16A2; the disease is Graves disease.